Editorial
Copyright ©The Author(s) 2025.
World J Clin Cases. Jul 26, 2025; 13(21): 106945
Published online Jul 26, 2025. doi: 10.12998/wjcc.v13.i21.106945
Table 1 Basic study information
Item
Content
Study typeRetrospective cohort study
ObjectiveTo evaluate the diagnostic performance of P-ADA as a biomarker for inflammatory pleural diseases
Sample size157 patients (exudates: 124 cases; transudates: 33 cases)
Key methodsROC curve analysis to determine optimal P-ADA cutoff; diagnostic parameters evaluated using Youden’s index
Main conclusionP-ADA ≥ 9.00 U/L demonstrates high diagnostic performance for inflammatory pleural effusions (AUC = 0.81, sensitivity = 77.69%)
Table 2 Diagnostic performance parameters (Receiver operating characteristic curve analysis)
Parameter
Result, %
95%CI
Optimal cutoff (U/L)≥ 9.00-
Sensitivity77.6969.22-84.75
Specificity68.7549.99-83.88
Positive predictive value 90.3883.03-95.29
Negative predictive value 44.9030.67-59.77
AUC value81.070.7174-0.8754
Diagnostic accuracy75.8268.24-82.37
Table 3 Distribution of pleural effusion etiologies
Etiology category
n (%)
Notes
Transudates (Non-inflammatory)33 (21)Congestive heart failure (26 cases), cirrhosis (3 cases), etc.
Exudates (Inflammatory)124 (79)Tuberculous effusion (44 cases), adenocarcinoma (37 cases), etc.
Other notable etiologies-Empyema (8 cases), lymphoma (7 cases), etc.